BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16696473)

  • 1. Potential impact of prostate edema on the dosimetry of permanent seed implants using the new 131Cs (model CS-1) seeds.
    Chen Z; Deng J; Roberts K; Nath R
    Med Phys; 2006 Apr; 33(4):968-75. PubMed ID: 16696473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription dose in permanent (131)Cs seed prostate implants.
    Yue N; Heron DE; Komanduri K; Huq MS
    Med Phys; 2005 Aug; 32(8):2496-502. PubMed ID: 16193779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of edema, relative biological effectiveness, and dose heterogeneity on prostate brachytherapy.
    Wang JZ; Mayr NA; Nag S; Montebello J; Gupta N; Samsami N; Kanellitsas C
    Med Phys; 2006 Apr; 33(4):1025-32. PubMed ID: 16696479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose calculation for permanent prostate implants incorporating spatially anisotropic linearly time-resolving edema.
    Monajemi TT; Clements CM; Sloboda RS
    Med Phys; 2011 Apr; 38(4):2289-98. PubMed ID: 21626964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of edema associated with 131Cs prostate permanent seed implants on dosimetric quality indices.
    Kehwar TS; Jones HA; Huq MS; Beriwal S; Benoit RM; Smith RP
    Med Phys; 2009 Aug; 36(8):3536-42. PubMed ID: 19746787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of edema on planning 125I and 103Pd prostate implants.
    Yue N; Dicker AP; Nath R; Waterman FM
    Med Phys; 1999 May; 26(5):763-7. PubMed ID: 10360539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimum timing for image-based dose evaluation of 125I and 103PD prostate seed implants.
    Yue N; Chen Z; Peschel R; Dicker AP; Waterman FM; Nath R
    Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1063-72. PubMed ID: 10571216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric effects of edema in permanent prostate seed implants: a rigorous solution.
    Chen Z; Yue N; Wang X; Roberts KB; Peschel R; Nath R
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1405-19. PubMed ID: 10889396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Edema-induced increase in tumour cell survival for 125I and 103Pd prostate permanent seed implants--a bio-mathematical model.
    Yue N; Chen Z; Nath R
    Phys Med Biol; 2002 Apr; 47(7):1185-204. PubMed ID: 11996063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isotope choice and the effect of edema on prostate brachytherapy dosimetry.
    Butler WM; Merrick GS; Dorsey AT; Lief JH
    Med Phys; 2000 May; 27(5):1067-75. PubMed ID: 10841411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between isotope half-life and prostatic edema for optimal prostate dose coverage in permanent seed implants.
    Villeneuve M; Leclerc G; Lessard E; Pouliot J; Beaulieu L
    Med Phys; 2008 May; 35(5):1970-7. PubMed ID: 18561673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of prostatic edema on 131Cs permanent prostate seed implants: a dosimetric and radiobiological study.
    Kehwar TS; Jones HA; Huq MS; Smith RP
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):621-7. PubMed ID: 20932692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of 125I or 103Pd seed implant of prostate.
    Yue N; Dicker AP; Corn BW; Nath R; Waterman FM
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):447-54. PubMed ID: 10030274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate brachytherapy postimplant dosimetry: seed orientation and the impact of dosimetric anisotropy in stranded implants.
    Chng N; Spadinger I; Rasoda R; Morris WJ; Salcudean S
    Med Phys; 2012 Feb; 39(2):721-31. PubMed ID: 22320782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
    Chibani O; Williamson JF; Todor D
    Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic edema in 125I permanent prostate implants: dynamical dosimetry taking volume changes into account.
    Leclerc G; Lavallée MC; Roy R; Vigneault E; Beaulieu L
    Med Phys; 2006 Mar; 33(3):574-83. PubMed ID: 16878561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Planning based on postneedle volume with early dosimetric assessment is beneficial for Cesium-131 permanent prostate seed implantation.
    Smith RP; Beriwal S; Komanduri K; Gibbons E; Benoit R
    Brachytherapy; 2008; 7(3):237-41. PubMed ID: 18599357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving toward focal therapy in prostate cancer: dual-isotope permanent seed implants as a possible solution.
    Todor DA; Barani IJ; Lin PS; Anscher MS
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):297-304. PubMed ID: 21536392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Edema-induced changes in tumor cell surviving fraction and tumor control probability in 131Cs permanent prostate brachytherapy implant patients.
    Kehwar TS; Jones HA; Huq MS; Smith RP
    J Appl Clin Med Phys; 2013 Jan; 14(1):3862. PubMed ID: 23318378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
    Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
    Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.